Processa Pharmaceuticals Files Q1 2025 10-Q
Ticker: PCSA · Form: 10-Q · Filed: May 8, 2025 · CIK: 1533743
| Field | Detail |
|---|---|
| Company | Processa Pharmaceuticals, Inc. (PCSA) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
**Processa Pharma Q1 2025 10-Q filed. Financials updated.**
AI Summary
Processa Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and operational results, including details on its lease liabilities. Specific financial figures for the current and prior periods are presented, reflecting the company's ongoing financial activities.
Why It Matters
This filing provides investors and stakeholders with an update on Processa Pharmaceuticals' financial health and operational status as of the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Processa Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Prior Year End Date (Provides a comparison point to the end of the previous fiscal year.)
- 2024-03-31 — Prior Year Q1 End Date (Allows for year-over-year comparison of Q1 performance.)
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations.)
Key Players & Entities
- Processa Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- 451539785 (dollar_amount) — EIN
- Heatwurx, Inc. (company) — Former company name
FAQ
What were Processa Pharmaceuticals' lease liabilities as of March 31, 2025?
The filing references specific sections for Operating and Finance Lease Liability Current and Noncurrent, indicating these figures are detailed within the report.
What is the company's primary industry classification?
Processa Pharmaceuticals, Inc. is classified under Pharmaceutical Preparations with SIC code 2834.
When was Processa Pharmaceuticals formerly known as?
The company was formerly known as Heatwurx, Inc., with a name change date of October 28, 2011.
What is the fiscal year end for Processa Pharmaceuticals?
The company's fiscal year ends on December 31st.
What is the SEC file number for Processa Pharmaceuticals?
The SEC file number for Processa Pharmaceuticals is 001-39531.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Processa Pharmaceuticals, Inc. (PCSA).